<DOC>
	<DOCNO>NCT01550237</DOCNO>
	<brief_summary>The clinical importance cone beam computer tomography base image guide radiotherapy ( CT- IGRT ) establish . The primary aim present trial investigate whether CT- IGRT consequently reduce safety margin reduce rectal side effect curative , high dose radiotherapy prostate cancer . Any impact reduce plan target volume CT- IGRT arm biochemical freedom disease evaluate secondary outcome . An open randomised phase III trial . The included men randomise receive curative radiotherapy 78 Gy 39 fraction weekly orthogonal position verification standard safety margin ( 10-15 mm ) 78 Gy 39 fraction daily CT position verification reduce safety margin ( 7mm ) .</brief_summary>
	<brief_title>Curative Image Guided Radiotherapy Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Biopsy confirm adenocarcinoma prostate No evidence nodal distant metastasis ( N0M0 ) Intermediate high risk base T stage , PSA level Gleason score Informed consent Previous treatment cancer last 5 year , except basal cell carcinoma skin Any previous radiotherapy , except KV electron treatment skin tumor outside pelvis Metallic hip joint replacement Preexisting intestinal genitourinary disease increase risk side effect Any preexisting condition make patient unsuitable radiotherapy Any preexisting condition make patient unsuitable hormonal therapy Any preexisting condition make patient unsuitable MRI . ALAT , GT , ALP , creatinin &gt; 1.5 x upper normal limit</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>radiotherapy , image-guided</keyword>
	<keyword>adverse effect</keyword>
	<keyword>position verification</keyword>
	<keyword>safety margin</keyword>
</DOC>